Related Experiment Videos
Isolated hyponatremia after transsphenoidal pituitary surgery
B R Olson1, D Rubino, J Gumowski
1Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
The Journal of Clinical Endocrinology and Metabolism
|January 1, 1995
Summary
Transsphenoidal surgery for Cushing's disease can cause hyponatremia in 21% of patients. Early monitoring and fluid restriction are key to managing this condition and ensuring good patient outcomes.
Area of Science:
- Endocrinology
- Neurosurgery
- Nephrology
Background:
- Cushing's disease is a complex endocrine disorder often treated with transsphenoidal surgery (TS).
- Postoperative fluid and sodium imbalances, particularly hyponatremia, are potential complications following TS.
- Understanding the incidence and contributing factors of hyponatremia is crucial for patient management.
Purpose of the Study:
- To investigate the incidence, timing, and potential associated factors of isolated hyponatremia after transsphenoidal surgery for Cushing's disease.
- To identify patient characteristics or surgical factors linked to the development of hyponatremia.
- To evaluate the clinical course and outcomes of patients experiencing hyponatremia post-TS.
Main Methods:
- Retrospective analysis of 58 patients undergoing TS for Cushing's disease over one year.
- Exclusion of patients with postoperative diabetes insipidus or volume depletion, focusing on 52 patients.
- Evaluation of plasma sodium levels, onset and duration of hyponatremia, and clinical symptoms.
Main Results:
- Isolated hyponatremia occurred in 21% of patients, with symptomatic hyponatremia (≤125 mmol/L) in 7%.
- Hyponatremia developed early postoperatively, progressing over 7 days, with maximum antidiuresis on day 7.
- Patients with a history of estrogenic milieu and posterior pituitary trauma had lower nadir plasma sodium levels.
Conclusions:
- Hyponatremia is a significant complication after TS for Cushing's disease, requiring careful monitoring.
- Unregulated vasopressin release may contribute to hyponatremia, though cortisol levels and adenoma size were not differentiating factors.
- Fluid restriction and active monitoring are effective in preventing severe morbidity and mortality in affected patients.